Age-related response to interferon alfa treatment in women vs men with chronic hepatitis C virus infection

Archives of Internal Medicine

Volumn 158, Issue 2, 1998, Pages 177-181

  Hoyoshi, Jun ^a   Kishihara, Yasuhiro ^a   Ueno, Kumiko ^a   Yamaji, Kouzaburo ^a   Kawakami, Yasunobu ^a   Furusyo, Norihiro ^a   Sawayama, Yasunori ^a   Kashiwagi, Seizaburo ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; VIRUS HEPATITIS;

ADULT; AGE FACTORS; ANTIVIRAL AGENTS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RNA, VIRAL; SEX FACTORS; TREATMENT OUTCOME;

EID: 15144359118     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.2.177     Document Type: Article

References (28)

1. Bruix J, Barrera JM, Calbet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 1989;2:1004-1006.
2. Colombo M, Kuo G, Choo QL, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989;2:1006-1008.
3. Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alfa: a multi-center randomized, controlled trial. N Engl J Med. 1989;321:1501-1506.
4. Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon alfa therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial. N Engl J Med. 1989;321:1506-1510.
5. Hagiwara M, Hayashi N, Mita E, et al. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α. Hepatology. 1992;15:37-41.
6. Hayashi J, Ohmiya M, Kishihara Y, et al. A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C. Am J Gastroenterol. 1994;89:2151-2156.
7. Nishiguchi S, Kuroki T, Nakatani S, et al. Randomised trial of effects of inter- feron-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet. 1995;346:1051-1055.
8. Yoshioka K, Kakumu S, Wakita T, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to geno-types of hepatitis C virus. Hepalology. 1992;16:293-299.
9. Lau JY, Davis GL, Kniffen J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 1993;341:1501-1504.
10. Suzuki T, Tanaka E, Matsumoto A, Urushihara A, Sodeyama T. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to Interferon α 2a therapy. J Med Virol. 1995;46:162-168.
11. Tsubota A, Chayama K, Arase Y, et al. Factors useful in predicting the response to interferon therapy in chronic hepatitis C. J Gastroenterol Hepatol. 1993;8:535-539.
12. Hayashi J, Kishihara Y, Yamaji K, et al. Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am J Gastroenterol. 1995;90:794-799.
13. Hayashi J, Nakashima K, Kishihara Y, et al. Improved detection of antibodies to hepatitis C virus by the second-generation assay in patients with chronic non-A, non-B liver disease. J Infect. 1993;26:287-294.
14. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome. Science. 1989;244:359-362.
15. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Med Virol. 1992;73:673-679.
16. Hayashi J, Yoshimura E, Kishihara Y, et al. Hepatitis C virus RNA levels determined by branched DNA probe assay correlated with levels assessed using competitive PCR. Am J Gastroenterol. 1996;91:314-318.
17. Simmonds P, Alberti A, Bonino F, et al. A proposed system for the nomenclature for genotypes of hepatitis C virus. Hepatology. 1994;19:1321-1324.
18. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M. Quantitation of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology. 1993;18:16-20.
19. Dixon WJ, Brown MB, Engelman L, Jennrich RI. BMDP Statistical Software Manual. Berkeley: University of California Press; 1990.
20. Chemello L, Cavalletto L, Casarin C, et al. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. Ann Intern Med. 1996;124:1058-1060.
21. Bresci G, Corso LD, Romanelli AM, Giuliano G, Pentimore F. The use of recombinant interferon alfa-2b in elderly patients with anti-HCV-positive chronic active hepatitis. J Am Geriatr Soc. 1993;41:857-862.
22. Horiike N, Masumoto T, Nakanishi K, et al. Interferon therapy for patients more than 60 years of age with chronic hepatitis C. J Gastroenterol Hepatol. 1995;10:246-249.
23. Garson JA, Brillanti S, Whitby M, et al. Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C. J Med Virol. 1995;45:348-353.
24. Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab. 1987;65:1231-1237.
25. MacNaughton J, Banah M, McCloud P, Hee J, Burger H. Age-related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age. Clin Endocrinol. 1992;36:339-345.
26. Polan ML, Daniele A, Kuo A. Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity. Fertil Steril. 1988;49:964-968.
27. Kishihara Y, Hayashi J, Yoshimura E, Yamaji K, Nakashima K, Kashiwagi S. IL-1β and TNF-α produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C. Dig Dis Sci. 1996;41:315-321,
28. Salamone LM, Pressman AR, Seeley DG, Cauley JA. Estrogen replacement therapy: a survey of older women's attitudes. Arch Intern Med. 1996;156:1293-1297.